Wall Street is positive on bluebird bio Inc (BLUE). On average, analysts give bluebird bio Inc a Buy rating. The average price target is $7.421, which means analysts expect the stock to climb by 95.80% over the next twelve months.
That average ranking earns bluebird bio Inc an Analyst Rating of 30, which is better than 30% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating BLUE a Buy today. Find out what this means to you and get the rest of the rankings on BLUE!
A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement.
InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.
What's Happening With bluebird bio Inc Stock Today?
bluebird bio Inc (BLUE) stock is trading at $3.79 as of 11:48 AM on Wednesday, Nov 22, a gain of $0.13, or 3.55% from the previous closing price of $3.66. The stock has traded between $3.63 and $3.85 so far today. Volume today is below average. So far 1,238,424 shares have traded compared to average volume of 3,991,797 shares.
Click Here to get the full Stock Report for bluebird bio Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
